trending Market Intelligence /marketintelligence/en/news-insights/trending/_Andhin-Zw7AQm47ZFpG5Q2 content esgSubNav
In This List

Spark Therapeutics raises $380.4M from common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Spark Therapeutics raises $380.4M from common stock offering

Spark Therapeutics Inc. closed its underwritten public offering of 5,296,053 common shares to raise net proceeds of about $380.4 million.

The offering included the 690,789 shares sold under the full exercise of the underwriters' option to buy additional shares at the public offering price of $76.00 per share, less the underwriting discount.

J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Co. LLC acted as book-running managers for the offering.